Navigation Links
Even healthy cats act sick when their routine is disrupted
Date:1/3/2011

and senior author of the study.

"We are cautious about extrapolating these findings to the average home, but we will say that anyone who has a pet accepts the responsibility of understanding their pet's needs and providing them," he added. "And what we've learned is that all cats need to have some consideration of environmental enrichment."

The study is published in the Jan. 1, 2011, issue of the Journal of the American Veterinary Medical Association.

This research project didn't begin as a study of cats' tendency to exhibit sickness behaviors. Ohio State's Veterinary Medical Center was housing 12 healthy cats and 20 cats with IC, including those at risk of euthanasia because their previous owners were unable to tolerate their sickness behaviors, for a variety of other research efforts, many related to better understanding the chronic disease.

Judi Stella, a doctoral candidate in veterinary preventive medicine, was the primary caretaker of this colony of cats. Based on previous work by Buffington about the benefits of environmental enrichment for cats that stay indoors, Stella spent months setting up a standardized feeding, play and cleaning schedule that seemed the least stressful for all of the cats.

And then she noticed that the cats with the chronic illness looked better: Their coats were shinier, their eyes were clearer and, perhaps most surprising of all, none of these cats missed the litter box or vomited for two weeks.

"At the time, we assumed the IC cats were always going to have these problems. When I started looking at the data, it was the lack of sickness behaviors that tipped me off. It was not expected," said Stella, lead author of the study.

"This became a study of enrichment as an approach to therapy for these syndromes because there is no good drug therapy in cats, or in people, for that matter, with this disorder. What we found, in other clinical studies and with this study,
'/>"/>

Contact: Tony Buffington
buffington.1@osu.edu
614-292-7987
Ohio State University
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Bee smart, bee healthy
2. Brandeis and Smart Balance team up to advance heart-healthy research
3. Tiny protein provokes healthy bonding between cells
4. How healthy are Americas coasts?
5. Modified gene targets cancer cells a thousand times more often than healthy cells
6. How healthy are Americas coasts?
7. Scientists can now differentiate between healthy cells and cancer cells
8. Young adults need to make more time for healthy meals
9. Scrawny gene keeps stem cells healthy
10. Gladstone scientists reveal that fat synthesizing enzyme is key to healthy skin and hair
11. Healthy food availability could depend on where you live -- so does the quality of your diet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... the leading source of biometrics industry news, interviews and thought ... "When we launched FindBiometrics 12 years ago the industry ... and CEO of FindBiometrics. "Now it,s maturing very quickly. More ... on a very broad scale.  We are known for providing ...
(Date:1/22/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the recent success of the Wocket™ smart wallet at CES 2015 ... wallet was named as one of the "11 Hot Products at CES" ... Launched At CES So Far" by Newseveryday.com and "The top 10 gadgets ...
(Date:1/22/2015)... 2015   EyeLock, Inc. , a market leader of iris-based ... Gerber to the new role of Senior Vice President ... development of mobile platforms and wearable solutions for EyeLock,s technologies. ... in the semiconductor industry to his role at EyeLock, with ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... medical device currently used for intestinal research, the colonsope, ... method has been developed, inspired by the way in ... received her PhD degree from TU Delft based on ... extremely difficult area to navigate through with a medical ...
... drug tamoxifen (Nolvadex®), which can become less effective over ... along with a second drug, according to new research ... Institute (NCI), part of the National Institutes of Health, ... 11, 2006, issue of Cancer Cell*. , Tamoxifen has ...
... Herceptin is borne by other patients whose treatment has to ... week’s BMJ. , New guidance from the National Institute for ... breast cancer, but it provides no extra funding and does ... extra money. This leaves medical staff with difficult decisions to ...
Cached Biology News:Like a snail through the intestinal canal 2Restoring tamoxifen sensitivity in resistant breast cancer cells 2Other patients bear the real cost of Herceptin 2
(Date:1/22/2015)... , Nueva Jersey , 22 de enero ... for Biomedical Research abre hoy su llamada a nominaciones ... cuya investigación científica ha hecho, o tiene el potencial ... salud humana. Las nominaciones se aceptarán hasta el 15 ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. ... company focused on advanced wound care, announces that ... tissues, have been added to the Premier, Inc. ... the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product ...
(Date:12/24/2014)... 2014  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical ... that the Company closed its previously announced private ... Jack W. Schuler , Birchview Fund LLC and ... before offering expenses.  The proceeds will be used ...
(Date:12/24/2014)... December 23, 2014 Earlier this year in ... director of the Adult Stem Cell Technology Center, LLC ( ... appreciated unique property of adult tissue stem cells. His ... Past, Important for the Future,” embodied the essence of his ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... July 11, 2011 Generex Biotechnology Corporation ( ... of studies conducted at the Mayo Clinic using ... Inc., the Company,s wholly-owned subsidiary, has used this ... vaccines for cancer.  AE37, an Ii-Key HER-2 hybrid, ...
... July 8, 2011 RegenoCELL Therapeutics, Inc. (OTCBB: RCLL) , ... announce the opening of another state of the art facility ... failure and peripheral artery disease with its autologous stem cell ... failure is administered at the Metropolitan Hospital in Athens, which ...
... , Amsterdam Molecular Therapeutics (Euronext: AMT), ... today that it has filed,a request for re-examination of ... European Medicines Agency.,Glybera is a gene therapy for the ... re-examination of,the dossier will be completed by the end ...
Cached Biology Technology:Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology 2Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology 3Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology 4Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology 5RegenoCELL Announces That Patients Can Be Treated With Its Autologous Stem Cell Therapy in Greece 2RegenoCELL Announces That Patients Can Be Treated With Its Autologous Stem Cell Therapy in Greece 3Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination 2
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... cell culture scale-up, these culture chambers produce ... 10 9 range and are useful ... flasks. • High mechanical • strength and ... to shipping • Certified nonpyrogenic and sterilized ...
Mouse monoclonal antibody to QARS - glutaminyl-tRNA synthetase...
... recombinant thermostable DNA polymerase obtained by high ... gene in E. coli, Concentration: 5U/ul, Applications: ... Fisher Scientific, the world leader in serving ... make the world healthier, cleaner and safer ...
Biology Products: